New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
06:34 EDTOGXIOncoGenex initiates Cedar clinical trial evaluating apatorsen
OncoGenex Pharmaceuticals announced initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating apatorsen in previously untreated patients with advanced squamous cell lung cancer. Apatorsen is a once-weekly intravenous experimental drug that is designed to inhibit production of heat shock protein 27 to disable cancer cells' defenses and overcome treatment resistance.
News For OGXI From The Last 14 Days
Check below for free stories on OGXI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2014
18:22 EDTOGXIOn The Fly: After Hours Movers
Subscribe for More Information
16:04 EDTOGXIOncoGenex announces update on on Phase 3 ENSPIRIT Trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use